Benitec Biopharma Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Oct. 15, 2024).

Benitec Biopharma Inc. filed a Form 424B5 with the U.S. Securities and Exchange Commission on October 15, 2024. The filing pertains to a prospectus submitted under Rule 424(b)(5) and includes contact information for the company based in Hayward, CA. This news article focuses on the business aspects of Benitec Biopharma Inc., highlighting its involvement in biopharmaceuticals and healthcare biotechnology. [Extracted from the article]